Connection

Kwok-Yung Yuen to Mice

This is a "connection" page, showing publications Kwok-Yung Yuen has written about Mice.
Connection Strength

1.005
  1. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters. Clin Infect Dis. 2021 06 15; 72(12):e978-e992.
    View in: PubMed
    Score: 0.056
  2. Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. Nat Commun. 2021 03 09; 12(1):1517.
    View in: PubMed
    Score: 0.055
  3. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Sci Adv. 2020 08; 6(35):eaba7910.
    View in: PubMed
    Score: 0.053
  4. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2. Nat Commun. 2020 08 25; 11(1):4252.
    View in: PubMed
    Score: 0.053
  5. Human tryptophanyl-tRNA synthetase is an IFN-?-inducible entry factor for Enterovirus. J Clin Invest. 2018 11 01; 128(11):5163-5177.
    View in: PubMed
    Score: 0.046
  6. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res. 2018 12; 160:38-47.
    View in: PubMed
    Score: 0.046
  7. Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production. Front Immunol. 2018; 9:2370.
    View in: PubMed
    Score: 0.046
  8. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza. Nat Commun. 2018 06 15; 9(1):2358.
    View in: PubMed
    Score: 0.045
  9. Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice. Arch Virol. 2018 Sep; 163(9):2349-2358.
    View in: PubMed
    Score: 0.045
  10. Mp1p homologues as virulence factors in Aspergillus fumigatus. Med Mycol. 2018 Apr 01; 56(3):350-360.
    View in: PubMed
    Score: 0.044
  11. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv. 2017 11; 3(11):eaao4966.
    View in: PubMed
    Score: 0.043
  12. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antiviral Res. 2017 Sep; 145:33-43.
    View in: PubMed
    Score: 0.042
  13. Improved detection of Zika virus RNA in human and animal specimens by a novel, highly sensitive and specific real-time RT-PCR assay targeting the 5'-untranslated region of Zika virus. Trop Med Int Health. 2017 05; 22(5):594-603.
    View in: PubMed
    Score: 0.041
  14. Talaromyces marneffei Mp1p Is a Virulence Factor that Binds and Sequesters a Key Proinflammatory Lipid to Dampen Host Innate Immune Response. Cell Chem Biol. 2017 Feb 16; 24(2):182-194.
    View in: PubMed
    Score: 0.041
  15. Isolation and Characterization of Dromedary Camel Coronavirus UAE-HKU23 from Dromedaries of the Middle East: Minimal Serological Cross-Reactivity between MERS Coronavirus and Dromedary Camel Coronavirus UAE-HKU23. Int J Mol Sci. 2016 May 07; 17(5).
    View in: PubMed
    Score: 0.039
  16. Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A. J Virol. 2015 Mar; 89(6):3076-92.
    View in: PubMed
    Score: 0.036
  17. An oral mucosal DNA vaccine for SARS coronavirus infections. Hong Kong Med J. 2009 Feb; 15 Suppl 2:41-2.
    View in: PubMed
    Score: 0.024
  18. Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. J Virol. 2009 Jan; 83(2):1026-35.
    View in: PubMed
    Score: 0.023
  19. Spike protein, S, of human coronavirus HKU1: role in viral life cycle and application in antibody detection. Exp Biol Med (Maywood). 2008 Dec; 233(12):1527-36.
    View in: PubMed
    Score: 0.023
  20. Studies of SARS virus vaccines. Hong Kong Med J. 2008 Aug; 14 Suppl 4:39-43.
    View in: PubMed
    Score: 0.023
  21. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
    View in: PubMed
    Score: 0.019
  22. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerg Microbes Infect. 2021 Dec; 10(1):874-884.
    View in: PubMed
    Score: 0.014
  23. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients. Cell Res. 2020 08; 30(8):702-704.
    View in: PubMed
    Score: 0.013
  24. SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection. Emerg Microbes Infect. 2019; 8(1):662-674.
    View in: PubMed
    Score: 0.012
  25. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection. BMC Infect Dis. 2018 04 25; 18(1):195.
    View in: PubMed
    Score: 0.011
  26. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses. Microbes Infect. 2017 12; 19(12):587-596.
    View in: PubMed
    Score: 0.011
  27. Gut-homing ?42PD1+Vd2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infection. Nat Microbiol. 2017 Oct; 2(10):1389-1402.
    View in: PubMed
    Score: 0.011
  28. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun. 2017 07 25; 8:15672.
    View in: PubMed
    Score: 0.011
  29. Immunotherapy Targeting Adenosine Synthase A Decreases Severity of Staphylococcus aureus Infection in Mouse Model. J Infect Dis. 2017 07 15; 216(2):245-253.
    View in: PubMed
    Score: 0.011
  30. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25; 6:22008.
    View in: PubMed
    Score: 0.010
  31. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
    View in: PubMed
    Score: 0.009
  32. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2015 Apr; 4(4):e26.
    View in: PubMed
    Score: 0.009
  33. Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases. PLoS One. 2013; 8(6):e66276.
    View in: PubMed
    Score: 0.008
  34. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar 20; 26(13):1644-51.
    View in: PubMed
    Score: 0.006
  35. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008 Jan 15; 180(2):948-56.
    View in: PubMed
    Score: 0.005
  36. Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity. Clin Vaccine Immunol. 2008 Feb; 15(2):194-202.
    View in: PubMed
    Score: 0.005
  37. Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines. Virology. 2006 Sep 15; 353(1):6-16.
    View in: PubMed
    Score: 0.005
  38. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005 Oct; 3(10):e324.
    View in: PubMed
    Score: 0.005
  39. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005 Jun; 79(12):7819-26.
    View in: PubMed
    Score: 0.005
  40. Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. Di Yi Jun Yi Da Xue Xue Bao. 2004 Jan; 24(1):1-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.